BridgeBio Pharma, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BridgeBio Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2019 to Q2 2024.
  • BridgeBio Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $7.27M, a 26% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $7.27M -$2.55M -26% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $8.05M -$2.48M -23.5% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $8.03M -$2.65M -24.8% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 $9.33M -$2.41M -20.5% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $9.81M -$3.04M -23.6% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $10.5M -$3.4M -24.4% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $10.7M -$5.23M -32.9% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $11.7M -$5.37M -31.4% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $12.9M -$3.11M -19.5% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $13.9M +$939K +7.23% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $15.9M -$601K -3.64% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $17.1M +$7.46M +77.4% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $16M +$5.5M +52.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $13M +$4.14M +46.8% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $16.5M +$6.51M +65.1% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $9.64M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $10.5M Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $8.86M Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $10M Dec 31, 2019 10-K 2020-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.